Miragen Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $2.8M | 200k | 13.98 |
| 2024-12-31 | $14M | 739k | 19.17 |
| 2024-09-30 | $23M | 1.0M | 22.75 |
| 2024-06-30 | $4.2M | 321k | 13.01 |
| 2024-03-31 | $9.8M | 563k | 17.51 |
| 2023-12-31 | $11M | 525k | 21.78 |
| 2023-09-30 | $5.1M | 334k | 15.34 |
| 2023-06-30 | $1.7M | 70k | 23.79 |
| 2022-12-31 | $9.8M | 335k | 29.21 |
| 2022-06-30 | $251k | 28k | 9.09 |
| 2022-03-31 | $640k | 35k | 18.32 |
| 2021-06-30 | $128k | 7.0k | 18.33 |